Clinical Trial: Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Chart Review on Patients With Unresectable/Metastatic Cholangiocarcinoma Treated in the UNM Cancer Center With a Combination of Irinotecan, Capecitabine and Celecoxib
Brief Summary: Chart Review on Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.
Detailed Summary: As above.
Sponsor: University of New Mexico
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of New Mexico
Dates:
Date Received: April 28, 2006
Date Started: November 2005
Date Completion:
Last Updated: January 6, 2010
Last Verified: December 2007